Association of Fibronectin, Leptin and LDL-Oxide Serum Levels With Coronary Artery Disease in Non-smoker and Non-diabetic Patients

Ali Reza Yaghoubi; Farank Kargar; Fatemeh Khaki-Khatibi

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jan 2016, Vol 3, Issue 1

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Association of Fibronectin, Leptin and LDL-Oxide Serum Levels With Coronary Artery Disease in Non-smoker and Non-diabetic Patients
Ali Reza Yaghoubi¹, Farank Kargar¹, Fatemeh Khaki-Khatibi²
¹Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran ²Drug Applied Research Center and Department of Clinical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
CJMB 2016; 3: 023-027 Viewed : 2707 times Downloaded : 6004 times. Keywords : Coronary artery disease, fibronectin, Leptin, LDL-oxide, Non-diabetic, Non-smoker
Full Text(PDF) \| Related Articles
Abstract

Objective: Coronary artery disease (CAD) is a leading cause of death of women and men worldwide. Endothelial dysfunction, smoker, diabetic, cell adhesion and oxidative stress may be considered as novel risk factors of CAD. These materials are cooperative events involved in atherosclerosis development. In the present study the serum levels of fibronectin, leptin and LDL-oxide were investigated in patients of CAD including non-smoker and non-diabetic with control group. Measurement of these parameters helps to prevent and treat the disease. Materials and Methods: In this study we measured serum levels of fibronectin, leptin and LDL-oxide in 200 individuals including 100 patients with CAD and 100 individuals as control group. Also patients with malignancy, renal and liver diseases and other disease were excluded from the study. Serum leptin and fibronectin were measured by enzyme-linked immunosorbent assay (ELISA) method using kits from German Imediagnostic and Chinese Crystal Day companies, respectively. Moreover, ELISA procedures were used to determine the serum LDL-oxide. Results: The serum levels of fibronectin, leptin and LDL-oxide were increased significantly as compared to control group (P ≤ 0.05 in all cases). It seems that there was strong (+) correlation between fibronectin, leptin and LDL-oxide in CAD. Conclusion: It was concluded that endothelial dysfunction, cell adhesion and stress oxidative are cooperative events involved in atherosclerosis development. Fibronectin, leptin and LDL-oxide have become greatly important in pathogenesis of CAD. Association between fibronectin, leptin and stress oxidative suggest that their involvement in development of atherosclerosis can be used as detective measure.